Stock Quote
Baxter International Inc (BAX.N) (New York Stock Exchange)
sector: Healthcare .
industry: Medical Equipment, Supplies & Distribution ยท
View BAX on other exchanges
$54.75
25 Nov 2009
-0.87%
$54.75
--
4,033,400
$55.50
$54.65
$60.99
$45.46
0.41
4,998,985
BAX.N
More News
| Press Releases
| Key Developments
| Name | Current Position | Compensation |
|---|---|---|
| Parkinson, Robert | Chairman of the Board, Chief Executive Officer | 16,006,600 |
| Davis, Robert | Chief Financial Officer, Corporate Vice President | 3,621,790 |
| Terrell, Karenann | Corporate Vice President, Chief Information Officer | -- |
Profile
Baxter International Inc. (Baxter) develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. As a diversified healthcare company, Baxter applies... Full Description
Company Address
Baxter International Inc
One Baxter Parkway
Deerfield IL 60015
P: +1847.9482000
F: +1847.9483642
One Baxter Parkway
Deerfield IL 60015
P: +1847.9482000
F: +1847.9483642
Analyst Research
Performance of Key Competitors
| Company | Price | Change |
|---|---|---|
| C.R. Bard, Inc. | $82.00 | -0.01 |
| Hospira, Inc. | $47.71 | +0.28 |
| Nektar Therapeutics | $8.92 | +0.22 |
| BAX.N | Industry | |
|---|---|---|
| P/E(TTM) | 15.37 | 3.91 |
| P/S(TTM) | 2.70 | 0.53 |
| ROI(TTM) | 17.56 | 2.66 |
| ROE(TTM) | 31.13 | 4.21 |
| Consensus Recommendation | Outperform |
|---|---|
| EPS Est. (Current Period) | 0.95 |
| EPS Est. (Current Year) | 3.80 |
| Total Revenue | $3,145.00M |
| Net Income | $532.00M |
| EPS | $0.87 |
